VX-710, Doxorubicin, and Vincristine for the Treatment of Patients With Recurrent Small Cell Lung Cancer

NCT00003847 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer

Interventions

DRUG: biricodar dicitrate
DRUG: doxorubicin hydrochloride
DRUG: vincristine sulfate

Sponsor

Vertex Pharmaceuticals Incorporated